# Stratus Properties Inc: financial statements, quarterly

STRS · OTC · CIK 885508 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/strs.md) · [Financials](/companies/strs/financials.md) · [Filings](/companies/strs/filings.md) · [Insiders](/companies/strs/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/strs/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [3.5](/filings/0000885508-24-000059.md) | [3.7](/filings/0000885508-24-000071.md) | [4.3 d](/filings/0000885508-24-000029.md) | [26.5](/filings/0000885508-25-000045.md) | [8.5](/filings/0000885508-25-000057.md) | [8.9](/filings/0000885508-25-000067.md) | [10.3 d](/filings/0000885508-26-000017.md) | [5.0](/filings/0000885508-26-000024.md) | [11.6](/filings/0000885508-25-000057.md) | [5.0](/filings/0000885508-25-000067.md) | [8.3 d](/filings/0000885508-26-000017.md) | [3.8](/filings/0000885508-26-000024.md) |
| Cost of revenue | $m | [4.8](/filings/0000885508-24-000059.md) | [3.8](/filings/0000885508-24-000071.md) | [3.7 d](/filings/0000885508-25-000022.md) | [18.4](/filings/0000885508-24-000053.md) | [7.6](/filings/0000885508-24-000059.md) | [8.7](/filings/0000885508-24-000071.md) | [8.4 d](/filings/0000885508-26-000017.md) | [4.8](/filings/0000885508-26-000024.md) | [13.8](/filings/0000885508-25-000057.md) | [9.2](/filings/0000885508-25-000067.md) | [9.3 d](/filings/0000885508-26-000017.md) | [5.7](/filings/0000885508-26-000024.md) |
| Operating income | $m | [(5.4)](/filings/0000885508-24-000059.md) | [(3.3)](/filings/0000885508-24-000071.md) | [(2.7) d](/filings/0000885508-25-000022.md) | [3.7](/filings/0000885508-25-000045.md) | [(2.9)](/filings/0000885508-25-000057.md) | [(1.5)](/filings/0000885508-25-000067.md) | [(1.4) d](/filings/0000885508-26-000017.md) | [(3.6)](/filings/0000885508-26-000024.md) | [(0.8)](/filings/0000885508-25-000057.md) | [(8.1)](/filings/0000885508-25-000067.md) | [23.2 d](/filings/0000885508-26-000017.md) | [15.4](/filings/0000885508-26-000024.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [0.5](/filings/0000885508-24-000059.md) | [0.4](/filings/0000885508-24-000071.md) | [(0.5) d](/filings/0000885508-25-000022.md) | [0.1](/filings/0000885508-25-000045.md) | [0.0](/filings/0000885508-25-000057.md) | [0.1](/filings/0000885508-25-000067.md) | [0.2 d](/filings/0000885508-26-000017.md) | [0.0](/filings/0000885508-26-000024.md) | [0.5](/filings/0000885508-25-000057.md) | [(0.3)](/filings/0000885508-25-000067.md) | [5.1 d](/filings/0000885508-26-000017.md) | [2.1](/filings/0000885508-26-000024.md) |
| Net income | $m | [(5.3)](/filings/0000885508-24-000059.md) | [(3.2)](/filings/0000885508-24-000071.md) | [(1.7) d](/filings/0000885508-25-000022.md) | [3.7](/filings/0000885508-25-000067.md) | [(2.8)](/filings/0000885508-25-000067.md) | [(1.4)](/filings/0000885508-25-000067.md) | [(1.4) d](/filings/0000885508-26-000017.md) | [(3.8)](/filings/0000885508-26-000024.md) | [(2.3)](/filings/0000885508-25-000067.md) | [(8.0)](/filings/0000885508-25-000067.md) | [16.9 d](/filings/0000885508-26-000017.md) | [13.5](/filings/0000885508-26-000024.md) |
| Diluted EPS | $ per share | [(0.66)](/filings/0000885508-24-000059.md) | [(0.36)](/filings/0000885508-24-000071.md) | not reported | [0.56](/filings/0000885508-25-000045.md) | [(0.21)](/filings/0000885508-25-000057.md) | [(0.05)](/filings/0000885508-25-000067.md) | not reported | [(0.36)](/filings/0000885508-26-000024.md) | [0.03](/filings/0000885508-25-000057.md) | [(0.62)](/filings/0000885508-25-000067.md) | not reported | [0.82](/filings/0000885508-26-000024.md) |
| Basic EPS | $ per share | [(0.66)](/filings/0000885508-24-000059.md) | [(0.36)](/filings/0000885508-24-000071.md) | not reported | [0.57](/filings/0000885508-25-000045.md) | [(0.21)](/filings/0000885508-25-000057.md) | [(0.05)](/filings/0000885508-25-000067.md) | not reported | [(0.36)](/filings/0000885508-26-000024.md) | [0.03](/filings/0000885508-25-000057.md) | [(0.62)](/filings/0000885508-25-000067.md) | not reported | [0.83](/filings/0000885508-26-000024.md) |

- Revenue: us-gaap:Revenues, us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue, us-gaap:CostOfGoodsAndServicesSold
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [44.1](/filings/0000885508-23-000036.md) | [35.2](/filings/0000885508-23-000055.md) | [31.4](/filings/0000885508-25-000022.md) | [20.7](/filings/0000885508-24-000053.md) | [13.5](/filings/0000885508-24-000059.md) | [19.6](/filings/0000885508-24-000071.md) | [20.2](/filings/0000885508-26-000017.md) | [12.0](/filings/0000885508-25-000045.md) | [59.4](/filings/0000885508-25-000057.md) | [55.0](/filings/0000885508-25-000067.md) | [74.3](/filings/0000885508-26-000024.md) | [73.5](/filings/0000885508-26-000024.md) |
| Total assets | $m | [486](/filings/0000885508-24-000059.md) | [502](/filings/0000885508-24-000071.md) | [518](/filings/0000885508-25-000022.md) | [510](/filings/0000885508-25-000045.md) | [514](/filings/0000885508-25-000057.md) | [523](/filings/0000885508-25-000067.md) | [533](/filings/0000885508-26-000017.md) | [535](/filings/0000885508-26-000024.md) | [575](/filings/0000885508-25-000057.md) | [573](/filings/0000885508-25-000067.md) | [563](/filings/0000885508-26-000024.md) | [532](/filings/0000885508-26-000024.md) |
| Total liabilities | $m | [187](/filings/0000885508-23-000036.md) | [206](/filings/0000885508-23-000055.md) | [223](/filings/0000885508-25-000022.md) | [210](/filings/0000885508-24-000053.md) | [217](/filings/0000885508-24-000059.md) | [223](/filings/0000885508-24-000071.md) | [235](/filings/0000885508-26-000017.md) | [242](/filings/0000885508-25-000045.md) | [236](/filings/0000885508-25-000057.md) | [240](/filings/0000885508-25-000067.md) | [216](/filings/0000885508-26-000024.md) | [182](/filings/0000885508-26-000024.md) |
| Shareholders' equity | $m | [195](/filings/0000885508-23-000036.md) | [192](/filings/0000885508-23-000055.md) | [191](/filings/0000885508-25-000022.md) | [198](/filings/0000885508-24-000053.md) | [196](/filings/0000885508-24-000059.md) | [196](/filings/0000885508-24-000071.md) | [195](/filings/0000885508-26-000017.md) | [191](/filings/0000885508-25-000045.md) | [192](/filings/0000885508-25-000057.md) | [186](/filings/0000885508-25-000067.md) | [204](/filings/0000885508-26-000024.md) | [212](/filings/0000885508-26-000024.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(8.4) d](/filings/0000885508-24-000059.md) | [(12.5) d](/filings/0000885508-24-000071.md) | [(12.0) d](/filings/0000885508-25-000022.md) | [6.5](/filings/0000885508-25-000045.md) | [(8.3) d](/filings/0000885508-25-000057.md) | [(0.7) d](/filings/0000885508-25-000067.md) | [(3.4) d](/filings/0000885508-26-000017.md) | [(13.5)](/filings/0000885508-26-000024.md) | [(1.7) d](/filings/0000885508-25-000057.md) | [(9.0) d](/filings/0000885508-25-000067.md) | [(5.8) d](/filings/0000885508-26-000017.md) | [(15.6)](/filings/0000885508-26-000024.md) |
| Dividends paid | $m | [0.4 d](/filings/0000885508-24-000059.md) | [0.1 d](/filings/0000885508-24-000071.md) | [0.0 d](/filings/0000885508-25-000022.md) | [0.4](/filings/0000885508-25-000045.md) | [0.0 d](/filings/0000885508-25-000057.md) | [0.0 d](/filings/0000885508-25-000067.md) | [0.0 d](/filings/0000885508-26-000017.md) | [0.2](/filings/0000885508-26-000024.md) | [0.0 d](/filings/0000885508-25-000057.md) | [0.0 d](/filings/0000885508-25-000067.md) | [0.0 d](/filings/0000885508-26-000017.md) | [0.0](/filings/0000885508-26-000024.md) |
| Share repurchases | $m | [0.7 d](/filings/0000885508-24-000059.md) | [0.5 d](/filings/0000885508-24-000071.md) | [0.1 d](/filings/0000885508-25-000022.md) | [0.0](/filings/0000885508-25-000045.md) | [0.0 d](/filings/0000885508-25-000057.md) | [0.0 d](/filings/0000885508-25-000067.md) | [1.6 d](/filings/0000885508-26-000017.md) | [0.4](/filings/0000885508-26-000024.md) | [0.1 d](/filings/0000885508-25-000057.md) | [1.4 d](/filings/0000885508-25-000067.md) | [1.2 d](/filings/0000885508-26-000017.md) | [0.5](/filings/0000885508-26-000024.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [8,383](/filings/0000885508-23-000036.md) | [8,275](/filings/0000885508-23-000055.md) | [7,986](/filings/0000885508-24-000053.md) | [7,990](/filings/0000885508-24-000059.md) | [8,003](/filings/0000885508-24-000071.md) | [8,151](/filings/0000885508-25-000045.md) | [8,072](/filings/0000885508-25-000057.md) | [8,080](/filings/0000885508-25-000067.md) | [8,037](/filings/0000885508-26-000024.md) | [8,176](/filings/0000885508-25-000057.md) | [8,033](/filings/0000885508-25-000067.md) | [8,055](/filings/0000885508-26-000024.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 7,982,723 at 2026-04-30, from the cover of the [10-Q filed 2026-05-12](/filings/0000885508-26-000024.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:27 ET. No prices; not investment advice.